230 related articles for article (PubMed ID: 37847613)
1. Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M; Visser EA; Hodgson K; Hipgrave Ederveen AL; Bastian K; Goode EA; Öztürk Ö; Pijnenborg JFA; Eerden N; Moons SJ; Rossing E; Wang N; de Haan N; Büll C; Boltje TJ; Munkley J
Glycobiology; 2023 Dec; 33(12):1155-1171. PubMed ID: 37847613
[TBL] [Abstract][Full Text] [Related]
2. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
3. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.
Saldova R; Fan Y; Fitzpatrick JM; Watson RW; Rudd PM
Glycobiology; 2011 Feb; 21(2):195-205. PubMed ID: 20861084
[TBL] [Abstract][Full Text] [Related]
4. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
5. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Sialylation in Cancer: Therapeutic Opportunities.
Munkley J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077781
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
8. The role of glycans in the development and progression of prostate cancer.
Munkley J; Mills IG; Elliott DJ
Nat Rev Urol; 2016 Jun; 13(6):324-33. PubMed ID: 27091662
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the human and bovine milk N-glycome via high-performance microfluidic chip liquid chromatography and tandem mass spectrometry.
Nwosu CC; Aldredge DL; Lee H; Lerno LA; Zivkovic AM; German JB; Lebrilla CB
J Proteome Res; 2012 May; 11(5):2912-24. PubMed ID: 22439776
[TBL] [Abstract][Full Text] [Related]
10. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
[TBL] [Abstract][Full Text] [Related]
11. Glycans as Biomarkers in Prostate Cancer.
Scott E; Munkley J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893936
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.
Hanzawa K; Tanaka-Okamoto M; Murakami H; Suzuki N; Mukai M; Takahashi H; Omori T; Ikezawa K; Ohkawa K; Ohue M; Natsuka S; Miyamoto Y
PLoS One; 2022; 17(4):e0266927. PubMed ID: 35413075
[TBL] [Abstract][Full Text] [Related]
13. Diet affects glycosylation of serum proteins in women at risk for cardiometabolic disease.
Kim T; Xie Y; Li Q; Artegoitia VM; Lebrilla CB; Keim NL; Adams SH; Krishnan S
Eur J Nutr; 2021 Oct; 60(7):3727-3741. PubMed ID: 33770218
[TBL] [Abstract][Full Text] [Related]
14. An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry.
Wallace EN; West CA; McDowell CT; Lu X; Bruner E; Mehta AS; Aoki-Kinoshita KF; Angel PM; Drake RR
Sci Rep; 2024 Jan; 14(1):489. PubMed ID: 38177192
[TBL] [Abstract][Full Text] [Related]
15. Targeting Aberrant Sialylation to Treat Cancer.
Munkley J; Scott E
Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31614918
[TBL] [Abstract][Full Text] [Related]
16. The Role of Glycosylation in Melanoma Progression.
De Vellis C; Pietrobono S; Stecca B
Cells; 2021 Aug; 10(8):. PubMed ID: 34440905
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis.
Ščupáková K; Adelaja OT; Balluff B; Ayyappan V; Tressler CM; Jenkinson NM; Claes BS; Bowman AP; Cimino-Mathews AM; White MJ; Argani P; Heeren RM; Glunde K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34752419
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation: Rising Potential for Prostate Cancer Evaluation.
Kałuża A; Szczykutowicz J; Ferens-Sieczkowska M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359624
[TBL] [Abstract][Full Text] [Related]
19. Altered linkage pattern of N-glycan sialic acids in pseudomyxoma peritonei.
Nummela P; Heiskanen A; Kytölä S; Haglund C; Lepistö A; Satomaa T; Ristimäki A
Glycobiology; 2021 Apr; 31(3):211-222. PubMed ID: 33539510
[TBL] [Abstract][Full Text] [Related]
20. Gestational diabetes mellitus affects the fucosylation and sialylation levels of N/O-glycans in human milk glycoproteins.
Wang X; Li Z; Li W; Li C; Liu J; Lu Y; Fan J; Ren H; Huang L; Wang Z
Carbohydr Polym; 2023 Feb; 301(Pt A):120312. PubMed ID: 36436856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
